Wednesday, October 28, 2026
Data from SEC filings, checked daily
Public filings, plainly told
WallStPal · PDF guide
KURA Insider Trading and Fund Holdings (Kura Oncology, Inc.) · https://wallstpal.com/stock/kura/ · saved 2026-10-28

About this page

Insider trades reported on SEC Form 4: when the people who run a company buy or sell its shares with their own money.

How to read it

Form 4
The form a company insider (officer, director or owner of more than 10%) must file with the SEC within two business days of buying or selling the company's shares.
Buy (P) and Sell (S)
Open-market purchases and sales. Gifts, option exercises and automatic tax withholding are left out because they say little about what the insider thinks.
Value
Shares times price, as reported on the filing.
10b5-1
A trade made under a plan set up in advance. Planned sales are common and usually say less than an unplanned purchase.
Late filing
A Form 4 filed more than two business days after the trade.
Vs. S&P 500
How the stock did after the trade minus how the overall market did in the same weeks.

A real example

In January 2016, when bank stocks were falling, JPMorgan Chase CEO Jamie Dimon bought 500,000 JPMorgan shares with his own money, worth about $26 million. His Form 4 made the purchase public within days, and investors read it as a strong sign of confidence.

Explain it like I'm 13

If the coach of a team bets his own allowance that his team will win, that tells you something. A Form 4 is the note a company boss must hand in whenever he buys or sells his own company's shares, so everyone can see it.

Data from public SEC filings and congressional reports. Information, not investment advice. Check every number against the filing linked on the page.

Summarize with AIChatGPTClaudePerplexityGoogle AIGrokCopilot
StockCIK 1422143

Kura Oncology, Inc. (KURA): Insider Trades and Fund Holdings

In the past 12 months, Kura Oncology, Inc. insiders reported 2 open-market purchases worth $2.35M and 12 sales worth $2.54M; 6 of the sales were reported as made under a 10b5-1 trading plan.

2Insider buys, 12 months
$2.35MBought by insiders, 12 months
$2.54MSold by insiders, 12 months
1Tracked funds holding

Timeline: news and trades

Company filings (8-K), insider trades, notices of planned sales (Form 144), Congress trades and fund moves in the past year, newest first.

  1. Sep 29, 2026Insider saleChief Medical Officer Mollie Leoni sold $309,567
  2. Sep 29, 2026Insider saleChief Commercial Officer Brian T. Powl sold $165,852
  3. Sep 29, 2026Insider saleCOO Kathleen Ford sold $39,437 under a 10b5-1 plan
  4. Sep 29, 2026Planned saleMOLLIE LEONI (officer) filed notice to sell about $305,589 around Sep 29, 2026
  5. Sep 29, 2026Planned saleBRIAN POWL (officer) filed notice to sell about $163,712 around Sep 29, 2026
  6. Sep 29, 2026Planned saleKATHLEEN FORD (officer) filed notice to sell about $38,917 around Sep 29, 2026
  7. Sep 28, 2026Insider saleChief Commercial Officer Brian T. Powl sold $179,184
  8. Sep 28, 2026Insider saleChief Medical Officer Mollie Leoni sold $130,670
  9. Sep 28, 2026Insider saleGeneral Counsel Teresa Brophy Bair sold $88,618 under a 10b5-1 plan
  10. Sep 28, 2026Insider saleCOO Kathleen Ford sold $72,494 under a 10b5-1 plan
  11. Sep 28, 2026Insider saleSVP Thomas James Doyle sold $48,361
  12. Sep 28, 2026Planned saleLEONI MOLLIE (officer) filed notice to sell about $133,940 around Sep 28, 2026
  13. Sep 28, 2026Planned salePOWL BRIAN T (officer) filed notice to sell about $97,055 around Sep 28, 2026
  14. Sep 28, 2026Planned saleBAIR TERESA BROPHY (officer) filed notice to sell about $90,836 around Sep 28, 2026
  15. Sep 28, 2026Planned saleBRIAN POWL (officer) filed notice to sell about $86,080 around Sep 28, 2026
  16. Sep 28, 2026Planned saleFORD KATHLEEN (officer) filed notice to sell about $74,309 around Sep 28, 2026
  17. Sep 28, 2026Planned saleDOYLE THOMAS JAMES (officer) filed notice to sell about $49,571 around Sep 28, 2026
  18. Sep 24, 2026Insider saleChief Scientific Officer Francis Burrows sold $224,514
  19. Sep 24, 2026Planned saleFRANCIS J BURROWS (officer) filed notice to sell about $224,514 around Sep 24, 2026
  20. Sep 8, 2026NewsCompany reported: Executive or director change
  21. Aug 24, 2026Insider buyCEO Troy Edward Wilson bought $1.2 million
  22. Aug 21, 2026Insider saleChief Commercial Officer Brian T. Powl sold $51,663 under a 10b5-1 plan (9 days after: quarterly or annual results)
  23. Aug 21, 2026Planned saleBRIAN POWL (officer) filed notice to sell about $50,880 around Aug 21, 2026
  24. Aug 19, 2026Insider saleGeneral Counsel Teresa Brophy Bair sold $397,681 under a 10b5-1 plan (7 days after: quarterly or annual results)
  25. Aug 19, 2026Planned saleTERESA BAIR (officer) filed notice to sell about $388,235 around Aug 19, 2026
  26. Aug 17, 2026Insider buyCEO Troy Edward Wilson bought $1.1 million (5 days after: quarterly or annual results)
  27. Aug 12, 2026NewsCompany reported: Quarterly or annual results
  28. Jul 29, 2026NewsCompany reported: Executive or director change
  29. Jun 30, 2026FundRenaissance Technologies added 5% in Q2 2026 (13F filed Aug 13, 2026)
  30. Jun 18, 2026Insider saleChief Medical Officer Mollie Leoni sold $834,283 under a 10b5-1 plan

Recent insider trades

Open-market purchases (code P) and sales (code S) from Form 4. Grants, option exercises and gifts are not shown. Latest filing: Sep 29, 2026.

Recent KURA insider trades
FiledTradedInsiderRoleTypeSharesPrice ($)ValueScoreHoldingFiling
Sep 29Sep 29Mollie LeoniChief Medical OfficerChief Medical Officer▼ SELL28,80210.75$310K−17%Form 4 ↗
Sep 29Sep 28Brian T. PowlChief Commercial OfficerChief Commercial Officer▼ SELL17,02010.53$179K−10%Form 4 ↗
Sep 29Sep 29Brian T. PowlChief Commercial OfficerChief Commercial Officer▼ SELL15,43010.75$166K−10%Form 4 ↗
Sep 29Sep 28Mollie LeoniChief Medical OfficerChief Medical Officer▼ SELL12,44810.50$131K−6.8%Form 4 ↗
Sep 29Sep 28Teresa Brophy BairGeneral CounselGeneral Counsel▼ SELL10b5-18,44210.50$89K−4.3%Form 4 ↗
Sep 29Sep 28Kathleen FordCOOCOO▼ SELL10b5-16,90610.50$72K−4.5%Form 4 ↗
Sep 29Sep 28Thomas James DoyleSVPSVP▼ SELL4,60710.50$48K−3.1%Form 4 ↗
Sep 29Sep 29Kathleen FordCOOCOO▼ SELL10b5-13,66810.75$39K−2.5%Form 4 ↗
Sep 25Sep 24Francis BurrowsChief Scientific OfficerChief Scientific Officer▼ SELL20,72610.83$225K−33%Form 4 ↗
Aug 24Aug 24Troy Edward WilsonCEOCEO (ind.)▲ BUY100,00012.39$1.24M47+26%Form 4 ↗
Source: SEC Form 4 filings, retrieved Oct 28, 2026. How we read filings
All 14 KURA insider trades →

Insiders who traded in the past year

InsiderRoleBuysBoughtSellsSoldLatest
Mollie LeoniChief Medical Officer0$03$1.27MSep 29, 2026
Brian T. PowlChief Commercial Officer0$03$397KSep 29, 2026
Teresa Brophy BairGeneral Counsel0$02$486KSep 29, 2026
Kathleen FordCOO0$02$112KSep 29, 2026
Thomas James DoyleSVP0$01$48KSep 29, 2026
Francis BurrowsChief Scientific Officer0$01$225KSep 25, 2026
Troy Edward WilsonCEO2$2.35M0$0Aug 24, 2026

Buybacks and executive pay

YearCEO pay reportedCEO pay "actually paid"Value of $100 invested
2025$4.74M$6.49Mn/a
2024$6.24M$4.23Mn/a
2023$5.25M$5.95Mn/a

From the company's XBRL data filed with the SEC. "Actually paid" is the SEC's pay-versus-performance measure, which counts changes in the value of stock awards. "Value of $100 invested" is the company's cumulative shareholder return as reported, usually measured from five years earlier. See all buybacks and CEO pay across companies.

Strongest purchase, 12 months

47 Troy Edward Wilson (CEO), 2026-08-24. What the score means

Filing quality

A All 14 insider trades reported on time. How it is graded

Tracked funds that report KURA

From each fund's latest 13F. Holdings are as of quarter end and are filed up to 45 days later.

FundQuarterSharesValue% of portfolioChange
Renaissance TechnologiesQ2 20261,663,765$18.3M0.03%▲ +5.1%
Source: SEC Form 13F-HR filings, retrieved Oct 28, 2026. How we read filings

Reading these numbers

Insiders sell for many reasons: taxes, diversification, a house. Purchases with their own money are rarer and are usually read as more informative. A Form 4 is due within two business days of the trade. How to read a Form 4 →